SMTL ID : 3r4l.1

Human very long half life Plasminogen Activator Inhibitor type-1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- BMA- BMA- FUC: beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-BMA-FUC.1: 5 residues within 4Å: Chain A: F.213, T.214, H.261, G.264, N.265 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.214

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 4 residues within 4Å: Chain A: N.209, E.225, P.227, K.263 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:E.225, A:P.227 Hydrogen bonds: A:K.263

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jankun, J. et al., Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure. Int.J.Mol.Med. (2012)

Release Date

2011-11-02

Peptides

Plasminogen activator inhibitor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Plasminogen activator inhibitor 1